Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide
- 1 March 1999
- journal article
- Published by Elsevier in Metabolism
- Vol. 48 (3) , 385-389
- https://doi.org/10.1016/s0026-0495(99)90090-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Investigation of Glucose-dependent Insulinotropic Polypeptide(1-42) and Glucagon-like Peptide-1-(7-36) Degradation by Dipeptidyl Peptidase IV Using Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass SpectrometryPublished by Elsevier ,1996
- Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IVEndocrinology, 1995
- Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing PolypeptideEndocrine Reviews, 1995
- Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivoJournal of Clinical Endocrinology & Metabolism, 1995
- Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serumEuropean Journal of Biochemistry, 1993
- Dipeptidyl Peptidase IV in the Immune System. Effects of Specific Enzyme Inhibitors on Activity of Dipeptidyl Peptidase IV and Proliferation of Human LymphocytesBiological Chemistry Hoppe-Seyler, 1991
- Recent Developments in Inhibiting Cysteine and Serine ProteasesJournal of Enzyme Inhibition, 1990
- Comparison of the Effects of Various C-Terminal and NTerminal Fragment Peptides of Glucagon-Like Peptide-1 on Insulin and Glucagon Release from the Isolated Perfused Rat Pancreas*Endocrinology, 1989
- Actions of GIPPeptides, 1981
- Entero-insular axisArchives of internal medicine (1960), 1969